Adherence and Patients' Experiences with the Use of Capecitabine in Daily Practice.

Capecitabine is a widely prescribed oral anticancer agent. We studied medication adherence and explored its use in daily practice from a patients' perspective. Patients ( = 92) starting capecitabine were followed up to five 3-week cycles.

The use of capecitabine in daily practice: a study on adherence and patients' experiences.

Background: Adherence to pharmacological therapy is a complex and multifactorial issue that can substantially alter the outcome of treatment. Especially when using long-term medication, cancer patients have adherence rates similar to those of patients with other diseases. The consequences of poor adherence are poor health outcomes and increased health care costs.

The use of erlotinib in daily practice: a study on adherence and patients' experiences.

Background: Adherence to pharmacological therapy is a complex and multi-factorial issue that can substantially alter the outcome of treatment. It has been shown that cancer patients, especially when using long-term medication, have similar adherence rates to those of patients with other diseases. The consequences of poor adherence are poor health outcomes and increased health care costs.